Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma

Not Recruiting

Trial ID: NCT00048984


Diagnostic trial to study genetic differences in patients who have Ewing's sarcoma. Genetic testing may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy.

Official Title

A Groupwide Biology and Banking Study for Ewing Sarcoma

Stanford Investigator(s)


Inclusion Criteria:

   - Newly diagnosed or recurrent Ewing's sarcoma

   - Availability of the following specimens:

      - Paraffin-embedded block or 20 unstained slides and 1-3 thick (50 micron) sections
      from initial biopsy

      - Pretreatment serum and whole blood

   - Concurrent therapy is not required


other: laboratory biomarker analysis

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs

New Trial Alerts